DiaCarta Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:DiaCarta Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12152
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
DiaCarta Inc (DiaCarta) is a developer of molecular diagnostics products for cancer and infectious diseases. The company offers genomic testing for biomarkers and also provides clinical sample testing services in their CLIA-certified lab. It offers products such as gene mutation detection kits, colon cancer tests, fusion gene detection tests, adapter dimer removal, DNA sample card, CRISPR gene editing, PCR ready lysis buffers and genotyping tests, among others. DiaCarta provides services including CLIA lab services; NGS target sequencing, next generation sequencing, companion diagnostics and CAR-T immunotherapy. The company markets its products through a channel of network distributors. It serves in Germany, Egypt, Iran, Turkey, Iraq and Costa Rica. DiaCarta is headquartered in Richmond, California, The US.

DiaCarta Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
DiaCarta Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
DiaCarta Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
DiaCarta Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
DiaCarta Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
DiaCarta Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
DiaCarta Inc, Medical Equipment, Deal Details 10
Venture Financing 10
DiaCarta Raises USD45 Million in Series B Financing 10
DiaCarta Raises USD8 Million in Series A Financing 11
Partnerships 12
DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 12
DiaCarta and MIODx Enter into Co-Development Agreement 13
DiaCarta Enters into Agreement with National Cancer Institute 14
DiaCarta and Pangaea Biotech Enter into Agreement 15
DiaCarta Inc – Key Competitors 16
DiaCarta Inc – Key Employees 17
DiaCarta Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Jul 31, 2018: DiaCarta Named to MedTech Outlook’s Top 10 In-Vitro Diagnostic Technology Solution Providers 2018 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
DiaCarta Inc, Medical Equipment, Key Facts 2
DiaCarta Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
DiaCarta Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
DiaCarta Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
DiaCarta Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
DiaCarta Inc, Deals By Market, 2012 to YTD 2018 8
DiaCarta Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
DiaCarta Raises USD45 Million in Series B Financing 10
DiaCarta Raises USD8 Million in Series A Financing 11
DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 12
DiaCarta and MIODx Enter into Co-Development Agreement 13
DiaCarta Enters into Agreement with National Cancer Institute 14
DiaCarta and Pangaea Biotech Enter into Agreement 15
DiaCarta Inc, Key Competitors 16
DiaCarta Inc, Key Employees 17

List of Figures
DiaCarta Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
DiaCarta Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
DiaCarta Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
DiaCarta Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
DiaCarta Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
DiaCarta Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
DiaCarta Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
DiaCarta Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[DiaCarta Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China Shipbuilding Industry Corporation:戦略・SWOT・企業財務分析
    China Shipbuilding Industry Corporation - Strategy, SWOT and Corporate Finance Report Summary China Shipbuilding Industry Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Meril Life Sciences Pvt Ltd:企業の製品パイプライン分析2018
    Summary Meril Life Sciences Pvt Ltd (Meril) is a medical device company that develops and designs clinically relevant devices. The company’s product categories include cardiovascular devices, vascular interventional devices, orthopedic devices, in-vitro diagnostics devices and endo-surgery devices. …
  • Bechtel Corporation-エネルギー分野:企業M&A・提携分析
    Summary Bechtel Corporation (Bechtel) is a provider of engineering, construction and project management services. It provides a diverse portfolio of services to energy, transportation, communications, mining, oil and gas, chemicals, water, nuclear and government customers across the world. Its major …
  • Coresa Sa:企業の戦略・SWOT・財務分析
    Coresa Sa - Strategy, SWOT and Corporate Finance Report Summary Coresa Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Essilor International S.A.:企業の戦略・SWOT・財務情報
    Essilor International S.A. - Strategy, SWOT and Corporate Finance Report Summary Essilor International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Voya Financial Inc:企業の戦略・SWOT・財務分析
    Voya Financial Inc - Strategy, SWOT and Corporate Finance Report Summary Voya Financial Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Vermont Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Vermont Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Etam Developpement SCA:企業の戦略・SWOT・財務情報
    Etam Developpement SCA - Strategy, SWOT and Corporate Finance Report Summary Etam Developpement SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Eli Lilly and Co (LLY):企業の財務・戦略的SWOT分析
    Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Biosynex SA (ALBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Biosynex SA (Biosynex), formerly All Diag Sarl is an in-vitro diagnostic company that manufactures, research, and develops rapid diagnostic tests. The company offers rapid diagnostic kits for diagnostic applications; and designing, self-measurement, and distributing thermometers. It offers t …
  • Reliance Capital Ltd:企業の戦略・SWOT・財務情報
    Reliance Capital Ltd - Strategy, SWOT and Corporate Finance Report Summary Reliance Capital Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • PTC KAMAZ:企業のM&A・事業提携・投資動向
    PTC KAMAZ - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PTC KAMAZ Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Topcon Corp (7732):企業の財務・戦略的SWOT分析
    Topcon Corp (7732) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • PQ Group Holdings Inc (PQG):企業の財務・戦略的SWOT分析
    PQ Group Holdings Inc (PQG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • H. Lee Moffitt Cancer Center & Research Institute Inc:医療機器:M&Aディール及び事業提携情報
    Summary H. Lee Moffitt Cancer Center & Research Institute Inc (Moffitt) is a healthcare service provider. It is engaged in the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services such a …
  • Sharjah Insurance Company P.S.C.:企業の戦略・SWOT・財務情報
    Sharjah Insurance Company P.S.C. - Strategy, SWOT and Corporate Finance Report Summary Sharjah Insurance Company P.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Therapix Biosciences Ltd (TRPX):製薬・医療:M&Aディール及び事業提携情報
    Summary Therapix Biosciences Ltd (Therapix), formerly Nasvax Ltd is a clinical stage biopharmaceutical company that focuses on the development of cannabinoid based pharmaceuticals for the treatment of central nervous system disorders. Therapix’s major product candidates include THX-110, for the trea …
  • Berry Global Group Inc:企業の戦略・SWOT・財務分析
    Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report Summary Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Damco International A/S:戦略・SWOT・企業財務分析
    Damco International A/S - Strategy, SWOT and Corporate Finance Report Summary Damco International A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • The Techint Group:企業の戦略・SWOT・財務情報
    The Techint Group - Strategy, SWOT and Corporate Finance Report Summary The Techint Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆